Literature DB >> 24623912

A comparative study of the different diagnostic criteria of gestational diabetes mellitus and its incidence.

Bl Somani1, Mm Arora2, Kapil Bhatia3, Devendra Arora4, Mithu Banerjee5.   

Abstract

BACKGROUND: High prevalence of diabetes and genetic predisposition to metabolic syndrome among Indians places Indian women at risk to develop gestational diabetes mellitus (GDM) and its complications. Literature defines multiple criteria for GDM. This prospective study compares available diagnostic criteria for GDM in Indian women and their correlation with perinatal morbidity.
METHOD: Nine hundred and forty-eight consecutive voluntary nondiabetic pregnant women were recruited for the study. Seven hundred and twenty-three of these (mean age 23.45 years; 75.7% < 25 years) who reported for the follow-up were screened for GDM at 24-28 weeks gestation by American College of Obstetrics and Gynaecology (ACOG) guidelines and World Health Organization (WHO) criteria. Glycated haemoglobin (HbA1c) and fasting and two-hours postglucose plasma insulin levels were also analysed. Pregnancy outcome was known for 291 of these. Concordance of risk factors and perinatal complications was analysed with respect to GDM.
RESULTS: Prevalence of GDM at 24-28 weeks gestation was found to be 4.8% by WHO criteria, 6.36% by Carpenter and Coustan's criteria, and 3.5% by O'Sullivan's criteria. Prevalence was marginally higher in women of higher age, having past history of abortion or family history of diabetes mellitus (DM) (P > 0.05). None of these women had HbA1c > 6%. Relative risk of abnormal delivery (pregnancy outcome) was 1.93, 1.39, and 1.17 in women with GDM by O'Sullivan's, WHO, and Carpenter's criteria, respectively (P > 0.05). Abnormal deliveries were marginally higher in women with high postglucose load insulin levels. Mean weight of the newborns was essentially the same in GDM and nonGDM women by any of the criteria. One-hour and two-hours postglucose values were more sensitive in diagnosing GDM by O'Sullivan's criteria while fasting plasma glucose value had the poorest specificity with 2.5% of nonGDM women having values above the cut-off. Modifications of these criteria did not im-prove their predictive value for abnormal delivery over that of O'Sullivan's criteria.
CONCLUSION: Prevalence of GDM and abnormal delivery in women < 35 years of age is low. Therefore, global screening for GDM may not be very useful in women < 25 years of age unless family history of DM or past history of abortion is present. Existing evidence is inadequate to justify the switchover from O'Sullivan's criteria for diagnosis of GDM.

Entities:  

Keywords:  Carpenter's criteria; GDM; O'Sullivan's criteria; WHO criteria

Year:  2012        PMID: 24623912      PMCID: PMC3862958          DOI: 10.1016/S0377-1237(11)60124-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  16 in total

1.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

3.  Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test.

Authors:  Ravi Retnakaran; Bernard Zinman; Philip W Connelly; Mathew Sermer; Anthony J G Hanley
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

4.  HbA1c in healthy, pregnant women.

Authors:  J K Radder; J van Roosmalen
Journal:  Neth J Med       Date:  2005 Jul-Aug       Impact factor: 1.422

5.  Gestational diabetes mellitus in India.

Authors:  V Seshiah; V Balaji; Madhuri S Balaji; C B Sanjeevi; A Green
Journal:  J Assoc Physicians India       Date:  2004-09

6.  Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population.

Authors:  B M Casey; M J Lucas; D D Mcintire; K J Leveno
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

7.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

8.  Genetic predisposition to type 2 diabetes among Asian Indians.

Authors:  V Radha; V Mohan
Journal:  Indian J Med Res       Date:  2007-03       Impact factor: 2.375

9.  Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project.

Authors:  M Sermer; C D Naylor; D J Gare; A B Kenshole; J W Ritchie; D Farine; H R Cohen; K McArthur; S Holzapfel; A Biringer
Journal:  Am J Obstet Gynecol       Date:  1995-07       Impact factor: 8.661

10.  Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women.

Authors:  Ghattu V Krishnaveni; Jacqueline C Hill; Sargoor R Veena; Suguna Geetha; Magudilu N Jayakumar; Chitra L S Karat; Caroline H D Fall
Journal:  Diabetes Res Clin Pract       Date:  2007-07-20       Impact factor: 5.602

View more
  3 in total

Review 1.  Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis.

Authors:  Katherine T Li; Shilpa Naik; Mallika Alexander; Jyoti S Mathad
Journal:  Acta Diabetol       Date:  2018-03-26       Impact factor: 4.280

2.  Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India.

Authors:  Karoline Kragelund Nielsen; Peter Damm; Anil Kapur; Vijayam Balaji; Madhuri S Balaji; Veerasamy Seshiah; Ib C Bygbjerg
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

3.  Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring.

Authors:  Martina Gáborová; Viera Doničová; Ivana Bačová; Mária Pallayová; Martin Bona; Igor Peregrim; Soňa Grešová; Judita Štimmelová; Barbora Dzugasová; Lenka Šalamonová Blichová; Viliam Donič
Journal:  Int J Environ Res Public Health       Date:  2021-03-25       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.